Access cutting-edge blood cancer treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access blood cancer specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related blood cancer treatment provided free
The goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving an HLA-Mismatched Unrelated Donor (MMUD) . The main question\[s\] it aims to answer are: * Does a reduced dose of PTCy reduce the occurrence of infections in the first 100 days after transplant? * Does a reduced dose of PTCy maintain the same level of protection against Graft Versus Host Disease (GvHD) as the standard
Sponsor: Center for International Blood and Marrow Transplant Research
Check if you qualify for this blood cancer clinical trial in Phoenix, AZ
If you're searching for blood cancer treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced blood cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.